ALBENDAMAX- 11.36% albendazole oral suspension
Albendamax by
Drug Labeling and Warnings
Albendamax by is a Animal medication manufactured, distributed, or labeled by Vetr, LLC, Alivira Animal Health. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
-
WARNINGS AND PRECAUTIONS
Important
Accurate estimates of the weight of the cattle, sheep, and goats to be treated are essential for effective results. Animals consistently exposed to internal parasites should be retreated as necessary.Residue Warnings
Cattle must not be slaughtered within 27 days following last treatment. Sheep and Goats must not be slaughtered within 7 days following last treatment. A withdrawal time in milk has not been established; Do not use in female breeding dairy cattle. Do not use in lactating female sheep or goats.Other Warnings
Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormers AND parasite management practices appropriate to the region and the animal(s) treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests should be used to determine if this product is appropriate, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored, e.g., fecal egg count reduction test. A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly.Precaution
Do not administer to female cattle during first 45 days of pregnancy or for 45 days after removal of bulls. Do not administer to ewes or does during the first 30 days of pregnancy or for 30 days after removal of rams or bucks. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. -
DOSAGE & ADMINISTRATION
Albendamax Suspension should be administered to cattle and goats at the recommended rate of 4 mL/100 lb of body weight (equivalent to 4.54 mg of albendazole/lb, 10 mg/kg) and to sheep at the recommended rate of 0.75 mL/25 lb of body weight (equivalent to 3.4 mg of albendazole/lb, 7.5 mg/kg). Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.
NOT FOR HUMAN USE. KEEP AWAY FROM CHILDREN. Use only as directed.
- STORAGE AND HANDLING
- ACTIVE INGREDIENT
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ALBENDAMAX
11.36% albendazole oral suspensionProduct Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC: 86213-442 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALBENDAZOLE (UNII: F4216019LN) (ALBENDAZOLE - UNII:F4216019LN) ALBENDAZOLE 113.6 mg in 1 mL Inactive Ingredients Ingredient Name Strength CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) 6 mg in 1 mL GLYCERIN (UNII: PDC6A3C0OX) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) POLYSORBATE 80 (UNII: 6OZP39ZG8H) BENZOIC ACID (UNII: 8SKN0B0MIM) Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 86213-442-01 240 mL in 1 BOTTLE, PLASTIC 2 NDC: 86213-442-02 500 mL in 1 BOTTLE, PLASTIC 3 NDC: 86213-442-03 960 mL in 1 BOTTLE, PLASTIC 4 NDC: 86213-442-04 1893 mL in 1 BOTTLE, PLASTIC 5 NDC: 86213-442-05 3785 mL in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 03/27/2026 Labeler - Vetr, LLC (132219984) Establishment Name Address ID/FEI Business Operations Vetr, LLC 132219984 manufacture, label Establishment Name Address ID/FEI Business Operations Alivira Animal Health 650916617 api manufacture
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.